Fundraising Fox
Auransa
11 employees on LinkedIn · 4 known investors
Find your way into Auransa
Sign up to see every warm intro you have to Auransa
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Auransa team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Auransa is a clinical-stage, AI-native biopharma company that analyzes large human disease datasets to discover and develop novel cancer therapies. It works collaboratively with pharmaceutical companies and academic institutions to advance its drug discovery programs.
Founders & leadership
PL
VV
Viwat VisuthikraiseeFounder
Investors · 4
11.2 Capitallisted by 11.2 CapitalLas Vegas · $500K – $3M
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
DCVC (Data Collective)listed by DCVC (Data Collective)Palo Alto · $5M – $25M
How we know: DCVC (Data Collective)'s portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Frequently asked questions
- What does Auransa do?
- Auransa is a clinical-stage, AI-native biopharma company that analyzes large human disease datasets to discover and develop novel cancer therapies. It works collaboratively with pharmaceutical companies and academic institutions to advance its drug discovery programs.
- Who founded Auransa?
- Auransa was founded by Pek Lum.
- Who are Auransa's investors?
- Auransa's investors include 11.2 Capital, DCVC (Data Collective), Harmonix Fund, Lux Capital.